EMA Approves Factor VIII Deficiency Clotting Drug
European Union marketing authorization recommended for Altuvoct for hemophilia A caused by factor VIII deficiency.
Stay updated with breaking news from Ebrile Response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
European Union marketing authorization recommended for Altuvoct for hemophilia A caused by factor VIII deficiency.
Republic of the Congo has declared an epidemic of mpox after 19 cases were confirmed across five departments, including the capital Brazzaville.
Omalizumab reduced the incidence of allergic reactions to multiple food items in a double-blind trial.
The new indication makes Xolair (omalizumab) the first drug approved to mitigate allergic reactions to more than one food.
Urologists must be prepared to question everything and start from scratch to get the right diagnosis, according to one expert.